Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Natriuretic peptides in heart failure].

M Emdin1, R Poletti, A Giannoni

  • 1U.O. Medicina Cardiovascolare, Istituto di Fisiologia Clinica del CNR, Pisa. emdin@ifc.cnr.it

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|April 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of the WHO Workload Indicators of Staffing Need (WISN) method to estimate workforce requirements in Italian Local Health Unit Prevention Departments.

BMC health services research·2026
Same author

Death occurred due to undiagnosed systemic amyloidosis: a case report.

La Clinica terapeutica·2022
Same author

A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany.

BMC health services research·2022
Same author

The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences.

Heart failure reviews·2021
Same author

Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2021
Same author

Hepatocellular carcinoma associated with direct-acting antiviral therapy for hepatitis C virus: A report of two cases.

Revista de gastroenterologia de Mexico (English)·2020

B-type natriuretic peptide (BNP) and NT-proBNP assays are valuable for diagnosing and assessing heart failure, aiding in risk stratification and patient follow-up. However, routine use to guide treatment decisions is not yet recommended.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biomarker Discovery

Context:

  • Cardiac endocrine function discovery
  • Development of natriuretic peptide assays
  • Established role in cardiovascular disease assessment

Purpose:

  • Evaluate the diagnostic and prognostic utility of B-type natriuretic peptide (BNP) and NT-proBNP in heart failure.
  • Assess the role of these biomarkers in screening, differential diagnosis, and risk stratification.
  • Examine their utility in guiding patient follow-up and treatment decisions.

Summary:

  • B-type natriuretic peptide (BNP) and NT-proBNP assays are crucial for heart failure assessment, offering value in diagnosis, differential diagnosis of dyspnea, and prognostic stratification.
  • Plasma BNP/NT-proBNP levels aid in evaluating chronic heart failure patients requiring risk stratification.

Related Experiment Videos

  • Italian recommendations highlight BNP/NT-proBNP's role in ruling out heart failure in patients with uncertain symptoms.

    • Impact:

    • Improved diagnostic accuracy for heart failure.
    • Enhanced risk stratification for cardiovascular disease patients.
    • Potential for optimized patient management and follow-up strategies.